1959Archives of General PsychiatryRequires access

Chlorpromazine, Triflupromazine, and Prochlorperazine in Chronic Psychosis

Thomas E. Hanlon

Open publisher page 6 citations

Abstract

As further phenothiazine tranquilizers become available in the treatment of the psychoses, there is an increasing need for comparative studies regarding their relative efficacy. A review of the literature indicates that such studies are now available on chlorpromazine and mepazine,1,2promazine and mepazine,3and promazine and chlorpromazine.4In a previous paper by us, the effects of chlorpromazine and triflupromazine were compared in the management of the chronic, hospitalized psychotic patient.5The following study is a continuation of the previous one, utilizing the same population and adding prochlorperazine as a final treatment phase. In this present paper the main emphasis will be on the comparative effectiveness of triflupromazine and prochlorperazine with original treatment with chlorpromazine serving as a base line. As previously, effectiveness is measured in terms of certain psychological dimensions observable in ward and interview behavior. Procedure The subjects originally selected

About this research paper

What this paper is about

As further phenothiazine tranquilizers become available in the treatment of the psychoses, there is an increasing need for comparative studies regarding their relative efficacy. A review of the literature indicates that such studies are now available on chlorpromazine and mepazine,1,2promazine and mepazine,3and promazine and chlorpromazine.4In a previous paper by us, the effects of chlorpromazine and triflupromazine were compared in the management of the chronic, hospitalized psychotic patient.5The following study is a continuation of the previous one, utilizing the same population and adding prochlorperazine as a final treatment phase. In this present paper the main emphasis will be on the comparative effectiveness of triflupromazine and prochlorperazine with original treatment with chlorpromazine serving as a base line. As previously, effectiveness is measured in terms of certain psychological dimensions observable in ward and interview behavior. Procedure The subjects originally selected

Why it matters

OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

As further phenothiazine tranquilizers become available in the treatment of the psychoses, there is an increasing need for comparative studies regarding their relative efficacy. A review of the literature indicates that such studies are now available on chlorpromazine and mepazine,1,2promazine and mepazine,3and promazine and chlorpromazine.4In a previous paper by us, the effects of chlorpromazine and triflupromazine were compared in the management of the chronic, hospitalized psychotic patient.5The following study is a continuation of the previous one, utilizing the same population and adding prochlorperazine as a final treatment phase. In this present paper the main emphasis will be on the comparative effectiveness of triflupromazine and prochlorperazine with original treatment with chlorpromazine serving as a base line. As previously, effectiveness is measured in terms of certain psychological dimensions observable in ward and interview behavior. Procedure The subjects originally selected

Key concepts: Promazine, Prochlorperazine, Chlorpromazine, Medicine, Psychosis, Psychiatry, Anesthesia, Psychology

Related papers

Back to paper searchBrowse research topicsOriginal source
Chlorpromazine, Triflupromazine, and Prochlorperazine in Chronic Psychosis — Research Paper | ScholarLens